Green Planet Bioengineering Co. Ltd.OTC: GPLB

Green Planet Bio Engineering Co. Ltd. 6M 2026: Net loss $(16,849), EPS < $0.01— 10-Q Summary

· Issued by Green Planet Bioengineering Co. Ltd.

Summary by 6ix AI

Green Planet Bio Engineering Co. Ltd., a public reorganized shell company with no active business operations, reported a consolidated net loss of $(16,849) for the six months ended June 30, 2026, versus a net loss of $(10,945) for the same period in 2025.

Key details

  • Diluted loss per share was less than $0.01 for the six months ended June 30, 2026 and for the six months ended June 30, 2025.
  • No revenue or sales activity was reported; expenses were limited to accounting and filing fees.
  • Operational funding was provided by a related-party majority stockholder.

What’s still pending

  • Future activities depend on securing investor funding.
  • Management intends to pursue acquisitions or mergers when opportunities arise.
  • Substantial doubt exists about the company's near-term viability.

6ix AI wrote this summary from the release below and checked it against the release.

Green Planet Bio Engineering Co. Ltd. reported a consolidated net loss of $(16,849) for the six months ended June 30, 2026, versus a net loss of $(10,945) for the same period in 2025. Diluted loss per share for the six-month period was less than $0.01 in both years.

Financial Highlights

  • Net income (loss): $(16,849) for 6M ended June 30, 2026, versus $(10,945) for 6M ended June 30, 2025 (consolidated net loss, year-to-date).
  • Diluted earnings per share: less than $0.01 loss per share for 6M ended June 30, 2026, versus less than $0.01 for 6M ended June 30, 2025.

Business Highlights

  • Operational status: The company remains a public reorganized shell with no active business operations during the reporting periods.
  • Revenue & channels: No revenue-generating channels or sales activity were reported; expenses were limited to accounting and filing fees.
  • Funding & liquidity: Operational funding was provided by a related-party majority stockholder; future activities depend on securing investor funding.
  • Going concern & outlook: Management intends to pursue acquisitions or mergers when opportunities arise, but substantial doubt exists about near-term viability.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Green Planet Bioengineering Co. Ltd. on 6ix